PI 3-kinase p55γ CRISPR Activation Plasmid (h): sc-402964-ACT
- Target species: human
- 20 µg of transfection-ready, purified plasmid DNA; Suitable for up to 20 transfections
- PI 3-kinase p55γ CRISPR Activation Plasmid (h) is a synergistic activation mediator (SAM) transcription activation system designed to specifically upregulate gene expression
- PI 3-kinase p55γ CRISPR Activation Plasmid (h) consists of three plasmids at a 1:1:1 mass ratio: a plasmid encoding the deactivated Cas9 (dCas9) nuclease (D10A and N863A) fused to the transactivation domain VP64, and a blasticidin resistance gene; a plasmid encoding the MS2-p65-HSF1 fusion protein, and a hygromycin resistance gene; a plasmid encoding a target-specific 20 nt guide RNA fused to two MS2 RNA aptamers, and a puromycin resistance gene
- The resulting SAM complex binds to a site-specific region approximately 200-250 nt upstream of the transcriptional start site and provides robust recruitment of transcription factors for highly efficient gene activation
- gRNAs encoded by PI 3-kinase p55γ CRISPR Activation Plasmid (h) and PI 3-kinase p55γ CRISPR Activation Plasmid (h2) target distinct regulatory regions upstream of the PIK3R3 transcriptional start site. One or both designs may be available
- Following transfection, gene knockout efficiency can be assayed by WB, IF or IHC using antibody: PI 3-kinase p55γ Antibody (E-9): sc-376615
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
PI 3-kinase p55γ CRISPR Activation Plasmid (h) | sc-402964-ACT | 20 µg | $397.00 | |||
PI 3-kinase p55γ CRISPR Activation Plasmid (h2) | sc-402964-ACT-2 | 20 µg | $397.00 |
PIK3R3 encodes the p55γ regulatory subunit of class IA phosphoinositide 3-kinase (PI3K), which associates with catalytic p110 isoforms to relay signals from activated receptor tyrosine kinases and adaptor proteins to downstream lipid second-messenger production. Through generation of PIP3, PI3K signaling coordinates AKT–mTOR axis activity, influencing cell growth, survival, metabolism, and cytoskeletal dynamics. Altered regulation of PI3K pathway components, including regulatory subunits that tune kinase output and receptor coupling, is frequently examined in contexts such as oncogenic signaling, insulin/IGF responses, and stress-adaptive programs. PIK3R3 is therefore studied for its contribution to pathway amplitude and feedback control that can shape phenotypes relevant to transformation, proliferation, and signaling plasticity.
PI 3-kinase p55γ CRISPR Activation Plasmid (h) provides a targeted, non-destructive approach to upregulating endogenous PIK3R3 expression without altering the underlying DNA sequence.
PI 3-kinase p55γ CRISPR Activation Plasmid (h) is a three-plasmid synergistic activation mediator (SAM) system engineered for highly efficient, site-specific transcriptional upregulation of the PIK3R3 locus in human cell lines. The system is built around a catalytically inactive Cas9 (dCas9) carrying two inactivating mutations (D10A and N863A) that eliminate nuclease activity while preserving DNA binding. This dCas9 is fused to VP64, a potent transcriptional activator, and is co-expressed with a blasticidin resistance gene for selection. The second plasmid encodes the MS2-p65-HSF1 fusion protein, a secondary activator complex that works in concert with dCas9-VP64, alongside a hygromycin resistance gene. The third plasmid encodes a target-specific 20 nt sgRNA fused to two MS2 RNA aptamers that recruit the MS2-p65-HSF1 complex to the activation site, accompanied by a puromycin resistance gene. The three plasmids are delivered at a 1:1:1 mass ratio for balanced expression of all system components.
Once assembled at the target locus, the SAM complex binds within approximately 200 bp upstream of the PIK3R3 transcriptional start site, where VP64, p65, and HSF1 act in concert to recruit transcriptional machinery and drive upregulation of endogenous PI 3-kinase p55γ expression. Unlike nuclease-active Cas9, dCas9 does not introduce double-strand breaks or modify the genomic sequence, preserving the native PIK3R3 locus and enabling the study of PI 3-kinase p55γ-dependent transcriptional responses at the endogenous locus, making it a valuable tool for functional studies, target gene identification, and the modeling of PI 3-kinase p55γ pathway restoration in tumor cells with silenced or reduced PIK3R3 expression.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.